FDA investigates concerns over weight loss medications
By Vuyile Madwantsi | Published Jan 4, 2024
The FDA later approved Semaglutide and Tirzepatide, marketed as Wegovy and Mounjaro, as weight loss treatments in 2021.
By Vuyile Madwantsi | Published Jan 4, 2024
The FDA later approved Semaglutide and Tirzepatide, marketed as Wegovy and Mounjaro, as weight loss treatments in 2021.
By The Washington Post | Published Jan 3, 2024
Ultra-processed foods make up a majority of the calories most people consume.
By Lutho Pasiya | Published Dec 29, 2023
By The Washington Post | Published Dec 19, 2023
By Gerry Cupido | Published Dec 14, 2023
By Bang Showbiz | Published Dec 14, 2023
By Vuyile Madwantsi | Published Dec 4, 2023
By Lutho Pasiya | Published Nov 29, 2023
By Lutho Pasiya | Published Nov 24, 2023
By Vuyile Madwantsi | Published Nov 14, 2023
By Lutho Pasiya | Published Nov 13, 2023
By Reuters | Published Nov 3, 2023
By Gerry Cupido | Published Nov 2, 2023
By Partnered Content | Published Nov 1, 2023
By Gerry Cupido | Published Oct 31, 2023
By Asian News | Published Oct 27, 2023